SBIR/STTR Research Award

Biodegradable Scaffolds Optimized for Cartilage Repair

Award identifier bc9dead29f60429b60e8fe3264bbff03431f55ef3fe010d46c133a82b1358c06Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
OSTEOBIOLOGICS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (Provided by Applicant): This project proposes the development of a biologically "friendly" scaffold for articular cartilage repair. Utilizing a fiber-reinforced, mechanically appropriate scaffold, the surface of the polymeric device will be coated with various cell attachment factors to improve the adherence and proliferation of cells/tissue. No synthetic scaffolds are currently approved in the U.S. for articular cartilage repair. Our long-range goal is to commercially produce an implant which, when combined with cells, can successfully heal cartilage defects. In this proposal, the objective is to evaluate the in vitro growth of articular chondrocytes on scaffolds coated with numerous treatments. The ability of the cell-laden, surface-treated scaffolds to form cartilage will also be confirmed subcutaneously in mice. This innovative project will enhance the biological properties of a synthetic scaffold so that minimal manipulation of added cells is required. Specific clinical indications include full thickness cartilage defects in weight-bearing regions of articulating joints, most frequently the knee. In Phase I we will identify at least one surface treatment/cell loading combination which shows superior cell/tissue growth in vitro and in vivo. Phase II will test the constructs in animals and prepare for clinical studies by testing potential sources for human cells. Regulatory approval and marketing plans will be finalized in Phase III. PROPOSED COMMERCIAL APPLICATIONS: From 1990-1996 total knee replacements procedures soared almost 90 percent. A reliable, cost-effective treatment for cartilage defects can stabilize further degeneration thus avoiding a total joint replacement. The proposed device will be placed in osteochondral/chondral defects to promote cartilage ingrowth in order to reestablish the articular joint surface. Benefits of such a device include off-the shelf availability, enhanced biological properties to reduce cell manipulation, and an environment conducive for tissue repair.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.